Reason for request
Inclusion on the list of products reimbursed by National Insurance and for hospital use in the extension of indication: "Symptomatic relief in the treatment of ankylosing spondylitis".
Clinical Benefit
| Substantial |
Le service médical rendu par ces spécialités est important dans l'extension d’indication : soulagement des symptômes dans le traitement de la spondylarthrite ankylosante.
|
Clinical Added Value
| no clinical added value |
Dans le traitement de la spondylarthrite ankylosante, CELEBREX® n'apporte pas d'amélioration du service médical rendu (V) par rapport aux autres AINS.
|
eNq1mFFv2jAQx9/5FFHeSQgtI5sC1cbaDalVGQVt2ktlkqOYuXZ6toHu088hVIMpUVeDH2M7/7v4/v75lORi88i8FaCkgvf8KGj5HvBUZJQ/9Pzp5KoZ+xf9RrIkK7K3rBu0gqjteykjUvb8YjaYAeEy+HFz/RnM+4B+v+ElYraEVB2s04qy4CuRixuSF2u8ZCVo5j2CWois5+dabUe9RCo0WfTXAn/JnKSQhLuR/dnl/fn+eBIWYv+hqiXgNeEPlaLArTRTjQhcDYiCB4HPNfmeWWlTOQYpNKYwImoxQrGiGWSVIeaESbAKMl9nd4ArBqoIUikeLtNHaSVOlmQzhqdhddIfzexAbVSz1Yy63fNWJ4racXzWsQqFe1tVXQXzEWF6H3fP47gdAg9TYDBD2FjWZiRQEeaoKlQODo3lKA7C06vVz6jMGXkOljK33SqCxEwDmuPv7kOKL5igARIze/aPPteMhW/MerrDhaOMCxoNhOaqhhpXY9uNGAiuYFNfUTvQqc3OixTk6WR/C14N+ZGeMZraIs1AR4NU0/GwnminhMEnImGK7mjwnfJMrOXpKbNfVUfZ51tQVormmEX37ffxu6jTsT5EP42Fam6YS40ih9Dwh8pjsDLkc3EsUIwrq6VePHkyO277HJESBjWdTtOSLcaHL42ZM6e7O0XlRKXol8uJrT2+acDnu+1jpTTNei+FteOuC5gbL9bm/XZnlwfcSQussRocC6Vy+SEM1+t1sCCyKYnZpWCOJwf73l3qrgF3cmGXDUwJR0epz8pb720Vsj1or13px7apu/d37XBlDIUajqhFyWRn5Bxenh7Gf3tUZ2mPDujhLsy2nySKCu6qz9GzSsWj8G/Kyq/Q8OF2Pqc1/0NqbZmE5b+YfiMJi/8w/cYft73lMA==
gkH165jUM1bmxVjN
